How have EPRX shares performed in 2024?

Eupraxia Pharmaceuticals' stock was trading at $2.72 on January 1st, 2024. Since then, EPRX stock has increased by 0.7% and is now trading at $2.74. View the best growth stocks for 2024 here .

How do I buy shares of Eupraxia Pharmaceuticals?

Shares of EPRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:EPRX

Eupraxia Pharmaceuticals (EPRX) Stock Price, News & Analysis

→ The biggest energy story ever? (From Porter & Company) (Ad)

Free EPRX Stock Alerts

$2.74

+0.04 (+1.48%)

(As of 04/30/2024 ET)

Compare

Today's Range: $2.65
▼
$2.74
50-Day Range: N/A
52-Week Range: $2.48
▼
$6.78

Volume: 6,609 shs
Average Volume: 20,892 shs
Market Capitalization: $74.75 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials SEC Filings Social Media

Get Eupraxia Pharmaceuticals alerts:

Ad Porter & Company

Trump’s last act as President

You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines.

For the full story, click here.

About Eupraxia Pharmaceuticals

Eupraxia Pharmaceuticals Inc. is a clinical-stage biotechnology company. It focused on the development of locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. Th company's lead product candidate includes EP-104IAR, for the treatment of pain due to osteoarthritis of the knee. Eupraxia Pharmaceuticals Inc. is based in VICTORIA, BC.

EPRX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

EPRX Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive EPRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eupraxia Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/30/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: N/A
Sub-Industry: N/A
Current Symbol: NASDAQ:EPRX
CUSIP: N/A
CIK: 1581178
Web: N/A
Phone: N/A
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 27,282,000
Free Float: N/A
Market Cap: $74.75 million
Optionable: N/A
Beta: N/A

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Key Competitors

View All Competitors

EPRX Stock Analysis - Frequently Asked Questions

How have EPRX shares performed in 2024?: Eupraxia Pharmaceuticals' stock was trading at $2.72 on January 1st, 2024. Since then, EPRX stock has increased by 0.7% and is now trading at $2.74.
View the best growth stocks for 2024 here.
How do I buy shares of Eupraxia Pharmaceuticals?: Shares of EPRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:EPRX) was last updated on 5/1/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial